Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review

Overview of attention for article published in American Journal of Reproductive Immunology, August 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 56 X posts from 52 X users, with an upper bound of 225,387 followers.

RT @ori_114: Does adding #hydroxychloroquine to empiric treatment improve the live birth rate in refractory #obstetrical #antiphospholipid…

RT @ori_114: Does adding #hydroxychloroquine to empiric treatment improve the live birth rate in refractory #obstetrical #antiphospholipid…

RT @ori_114: Does adding #hydroxychloroquine to empiric treatment improve the live birth rate in refractory #obstetrical #antiphospholipid…

RT @ori_114: Does adding #hydroxychloroquine to empiric treatment improve the live birth rate in refractory #obstetrical #antiphospholipid…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 52 additional X posts.